Transbuccal insulin (MidaSol)

N/A

Report date: 2022/01/24 17:20:38

Base Information

Drug NameTransbuccal insulin (MidaSol)

Drug Alias NameMidaForm insulin PharmFilmInsulin buccal soluble film - Midatech PharmaInsulin nanoparticles buccal film - MidasolNanoparticle insulinInsulin - MidaSol +[9]

ClassificationBiologics

Mechanisms of ActionInsulin receptor agonists

TargetsInsulin receptor

Therapy Area/IndicationsDiabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBiodexa Pharmaceuticals PLC Aquestive Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiodexa Pharmaceuticals PLC Aquestive Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A